BioSculpture Technology

About BioSculpture Technology

BioSculpture Technology, Inc. (BST) specializes in advanced power-assisted dual cannula tissue aspiration systems, primarily serving the cosmetic surgery market. The company operates in the medical device sector, focusing on affluent populations where obesity rates are high and increasing. BST's core product, the ARC Systems Reciprocating Cannula, is a disposable, gas-powered assembly that simplifies tissue removal during liposuction procedures. This system is manufactured by Byron Medical and is uniquely driven by a vacuum system, eliminating the need for tanked gas or electricity. The product is delivered in sterile packages, ensuring safety and convenience for medical professionals. BST's business model revolves around licensing its innovative liposuction technology, originally developed by Rocin Laboratories, Inc. The company generates revenue through licensing agreements and the sale of its specialized medical devices. By offering a more controlled and efficient method for tissue removal, BST aims to capture a significant share of the cosmetic surgery market, which is expected to grow as obesity rates continue to rise.